{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T21:54:25Z","timestamp":1767650065246,"version":"3.41.2"},"reference-count":26,"publisher":"BMJ","issue":"11","license":[{"start":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T00:00:00Z","timestamp":1604966400000},"content-version":"unspecified","delay-in-days":9,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Glob Health"],"accepted":{"date-parts":[[2020,10,6]]},"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Opioids are deemed essential medicines by the World Health Organization (WHO). However, many countries have inadequate access to them. Whether including opioids in national essential medicines lists (EMLs) influences national opioid consumption has not been evaluated.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We conducted a cross-sectional study to determine whether the listing of opioids in national EMLs was associated with consumption. We quantified the numbers and types of all opioids included in 137 national EMLs, for comparison with opioids in the WHO\u2019s Model List of Essential Medicines. Using the International Narcotics Control Board (INCB) consumption statistics for 2015\u20132017, we assessed the relation between annual mean opioid consumption (mg\/person) and the numbers of opioids included in EMLs, controlling for region, population, healthcare expenditure, life expectancy, gross domestic product, human development and corruption.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Five opioids were included in the 20th edition of the WHO\u2019s Model List of Essential Medicines: codeine, fentanyl, loperamide, methadone and morphine. On average, countries\u2019 lists included significantly (p&lt;0.05) more opioids than the WHO\u2019s Model List. However, there were wide variations in the numbers (median 6 opioids; IQR: 5\u20139) and types (n=33) of opioids included in national EMLs. Morphine (95%), fentanyl (83%) and codeine (69%) were the most commonly included opioids. Most national EMLs were out of date (median publication date: 2011, IQR: 2009\u20132013). After adjusting for country characteristics, there was no relation between mean opioid consumption and the number of opioids in EMLs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Including opioids in national EMLs was not associated with consumption. National EMLs should be regularly updated to reflect the availability of opioids and the populations\u2019 needs for managing pain.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjgh-2020-003563","type":"journal-article","created":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T16:47:26Z","timestamp":1605026846000},"page":"e003563","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":21,"title":["Relation between opioid consumption and inclusion of opioids in 137 national essential medicines lists"],"prefix":"10.1136","volume":"5","author":[{"given":"Georgia C","family":"Richards","sequence":"first","affiliation":[{"name":"Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, Oxfordshire, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey K","family":"Aronson","sequence":"additional","affiliation":[{"name":"Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, Oxfordshire, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl","family":"Heneghan","sequence":"additional","affiliation":[{"name":"Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, Oxfordshire, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamal R","family":"Mahtani","sequence":"additional","affiliation":[{"name":"Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, Oxfordshire, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constantinos","family":"Koshiaris","sequence":"additional","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, Oxfordshire, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nav","family":"Persaud","sequence":"additional","affiliation":[{"name":"Department of Family and Community Medicine, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada"},{"name":"Centre for Urban Health Solutions, Department of Family and Community Medicine, St Michael's Hospital, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,11,10]]},"reference":[{"key":"2025073013174166000_5.11.e003563.1","unstructured":"WHO . 20Th essential medicines list, 2017. Available: https:\/\/www.who.int\/medicines\/news\/2017\/20th_essential_med-list\/en\/ LB - HW7p"},{"key":"2025073013174166000_5.11.e003563.2","unstructured":"WHO Expert Committee on the Selection of Essential Drugs & World Health Organization . The selection of essential drugs : report of a WHO expert committee [meeting held in Geneva from 17 to 21 October 1977], 1977. Available: https:\/\/apps.who.int\/iris\/handle\/10665\/41272"},{"key":"2025073013174166000_5.11.e003563.3","doi-asserted-by":"publisher","DOI":"10.1136\/bmjebm-2018-110979"},{"key":"2025073013174166000_5.11.e003563.4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001724","article-title":"Who essential medicines policies and use in developing and transitional countries: an analysis of reported policy implementation and medicines use surveys","volume":"11","author":"Holloway","year":"2014","journal-title":"PLoS Med"},{"key":"2025073013174166000_5.11.e003563.5","doi-asserted-by":"crossref","first-page":"394","DOI":"10.2471\/BLT.18.222448","article-title":"Comparison of essential medicines Lists in 137 countries","volume":"97","author":"Persaud","year":"2019","journal-title":"Bull World Health Organ"},{"key":"2025073013174166000_5.11.e003563.6","doi-asserted-by":"publisher","DOI":"10.1097\/01.j.pain.0000460356.94374.a1"},{"key":"2025073013174166000_5.11.e003563.7","first-page":"266","article-title":"Canadian list of essential medications: potential and uncertainties","volume":"63","author":"Persaud","year":"2017","journal-title":"Can Fam Physician"},{"key":"2025073013174166000_5.11.e003563.8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.329.7475.1169"},{"key":"2025073013174166000_5.11.e003563.9","unstructured":"Persaud N , Jiang M , Shaikh R , et al . Global essential medicines database. Figshare 2019."},{"key":"2025073013174166000_5.11.e003563.10","unstructured":"Thomas J . Availability of narcotic drugs for medical use. Int. Narc. Control Board 2019."},{"key":"2025073013174166000_5.11.e003563.11","doi-asserted-by":"crossref","unstructured":"Richards GC , Aronson JK , Heneghan C , et al . Opioid consumption and the inclusion of opioids in 137 national essential medicines lists., 2020. Open Science Framework DOI: 10.17605\/OSF.IO\/385HX. Available: https:\/\/osf.io\/385hx\/[Accessed Sept 09, 2020].","DOI":"10.1136\/bmjgh-2020-003563"},{"key":"2025073013174166000_5.11.e003563.12","unstructured":"INCB . Mandate-functions. Int. Narc. Control Board 2019."},{"key":"2025073013174166000_5.11.e003563.13","unstructured":"WHO . Global health Observatory data Repository. World Heal. Stat 2019."},{"key":"2025073013174166000_5.11.e003563.14","unstructured":"WHO . Who model Lists of essential medicines, 2019. Available: http:\/\/www.who.int\/medicines\/publications\/essentialmedicines\/en\/ [Accessed 8 Sep 2020]."},{"key":"2025073013174166000_5.11.e003563.15","unstructured":"United Nations . Member states, 2019. Available: https:\/\/www.un.org\/en\/member-states\/ [Accessed 13 Feb 2020]."},{"key":"2025073013174166000_5.11.e003563.16","unstructured":"StataCorp . Stata statistical software 2019."},{"key":"2025073013174166000_5.11.e003563.17","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.jpainsymman.2013.12.237","article-title":"Cross-Sectional pilot study to monitor the availability, dispensed prices, and affordability of opioids around the globe","volume":"48","author":"De Lima","year":"2014","journal-title":"J Pain Symptom Manage"},{"key":"2025073013174166000_5.11.e003563.18","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4257"},{"key":"2025073013174166000_5.11.e003563.19","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2017-000571"},{"key":"2025073013174166000_5.11.e003563.20","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2018-001379"},{"key":"2025073013174166000_5.11.e003563.21","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2018-001306"},{"key":"2025073013174166000_5.11.e003563.22","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ajic.2016.10.014","article-title":"A tale of 2 HIV outbreaks caused by unsafe injections in Cambodia and the United States, 2014-2015","volume":"45","author":"Gokhale","year":"2017","journal-title":"Am J Infect Control"},{"key":"2025073013174166000_5.11.e003563.23","doi-asserted-by":"publisher","DOI":"10.1080\/105761000265548"},{"key":"2025073013174166000_5.11.e003563.24","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/S0140-6736(16)00161-6","article-title":"Use of and barriers to access to opioid analgesics: a worldwide, regional, and national study","volume":"387","author":"Berterame","year":"2016","journal-title":"The Lancet"},{"key":"2025073013174166000_5.11.e003563.25","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00161-6"},{"key":"2025073013174166000_5.11.e003563.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2012.03.011"}],"container-title":["BMJ Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjgh-2020-003563","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T20:17:48Z","timestamp":1753906668000},"score":1,"resource":{"primary":{"URL":"https:\/\/gh.bmj.com\/lookup\/doi\/10.1136\/bmjgh-2020-003563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":26,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,11,10]]},"published-print":{"date-parts":[[2020,11]]}},"alternative-id":["10.1136\/bmjgh-2020-003563"],"URL":"https:\/\/doi.org\/10.1136\/bmjgh-2020-003563","relation":{},"ISSN":["2059-7908"],"issn-type":[{"type":"electronic","value":"2059-7908"}],"subject":[],"published":{"date-parts":[[2020,11]]}}}